Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies
• Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent w...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Nosaki, Kaname [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation - Garrote, Pedro J. ELSEVIER, 2019, journal of the International Association for the Study of Lung Cancer, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:135 ; year:2019 ; pages:188-195 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.lungcan.2019.07.004 |
|---|
| Katalog-ID: |
ELV047696990 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047696990 | ||
| 003 | DE-627 | ||
| 005 | 20230624140810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191022s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2019.07.004 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica |
| 035 | |a (DE-627)ELV047696990 | ||
| 035 | |a (ELSEVIER)S0169-5002(19)30527-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nosaki, Kaname |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies |
| 264 | 1 | |c 2019 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. | ||
| 650 | 7 | |a ESMO |2 Elsevier | |
| 650 | 7 | |a JLCS |2 Elsevier | |
| 650 | 7 | |a ECOG PS |2 Elsevier | |
| 650 | 7 | |a AE |2 Elsevier | |
| 650 | 7 | |a NSCLC |2 Elsevier | |
| 650 | 7 | |a OS |2 Elsevier | |
| 650 | 7 | |a Q3W |2 Elsevier | |
| 650 | 7 | |a TPS |2 Elsevier | |
| 650 | 7 | |a PD-L1 |2 Elsevier | |
| 650 | 7 | |a HR |2 Elsevier | |
| 650 | 7 | |a PD-1 |2 Elsevier | |
| 700 | 1 | |a Saka, Hideo |4 oth | |
| 700 | 1 | |a Hosomi, Yukio |4 oth | |
| 700 | 1 | |a Baas, Paul |4 oth | |
| 700 | 1 | |a de Castro, Gilberto |4 oth | |
| 700 | 1 | |a Reck, Martin |4 oth | |
| 700 | 1 | |a Wu, Yi-Long |4 oth | |
| 700 | 1 | |a Brahmer, Julie R. |4 oth | |
| 700 | 1 | |a Felip, Enriqueta |4 oth | |
| 700 | 1 | |a Sawada, Takeshi |4 oth | |
| 700 | 1 | |a Noguchi, Kazuo |4 oth | |
| 700 | 1 | |a Han, Shi Rong |4 oth | |
| 700 | 1 | |a Piperdi, Bilal |4 oth | |
| 700 | 1 | |a Kush, Debra A. |4 oth | |
| 700 | 1 | |a Lopes, Gilberto |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Garrote, Pedro J. ELSEVIER |t Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |d 2019 |d journal of the International Association for the Study of Lung Cancer |g Amsterdam [u.a.] |w (DE-627)ELV002331438 |
| 773 | 1 | 8 | |g volume:135 |g year:2019 |g pages:188-195 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lungcan.2019.07.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 135 |j 2019 |h 188-195 |g 8 | ||
| author_variant |
k n kn |
|---|---|
| matchkey_str |
nosakikanamesakahideohosomiyukiobaaspaul:2019----:aeynefccopmrlzmboohrpiedryainsihd1oiiedacdosalelugacroldnlssr |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1016/j.lungcan.2019.07.004 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica (DE-627)ELV047696990 (ELSEVIER)S0169-5002(19)30527-6 DE-627 ger DE-627 rakwb eng Nosaki, Kaname verfasserin aut Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Elsevier Saka, Hideo oth Hosomi, Yukio oth Baas, Paul oth de Castro, Gilberto oth Reck, Martin oth Wu, Yi-Long oth Brahmer, Julie R. oth Felip, Enriqueta oth Sawada, Takeshi oth Noguchi, Kazuo oth Han, Shi Rong oth Piperdi, Bilal oth Kush, Debra A. oth Lopes, Gilberto oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:135 year:2019 pages:188-195 extent:8 https://doi.org/10.1016/j.lungcan.2019.07.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 135 2019 188-195 8 |
| spelling |
10.1016/j.lungcan.2019.07.004 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica (DE-627)ELV047696990 (ELSEVIER)S0169-5002(19)30527-6 DE-627 ger DE-627 rakwb eng Nosaki, Kaname verfasserin aut Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Elsevier Saka, Hideo oth Hosomi, Yukio oth Baas, Paul oth de Castro, Gilberto oth Reck, Martin oth Wu, Yi-Long oth Brahmer, Julie R. oth Felip, Enriqueta oth Sawada, Takeshi oth Noguchi, Kazuo oth Han, Shi Rong oth Piperdi, Bilal oth Kush, Debra A. oth Lopes, Gilberto oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:135 year:2019 pages:188-195 extent:8 https://doi.org/10.1016/j.lungcan.2019.07.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 135 2019 188-195 8 |
| allfields_unstemmed |
10.1016/j.lungcan.2019.07.004 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica (DE-627)ELV047696990 (ELSEVIER)S0169-5002(19)30527-6 DE-627 ger DE-627 rakwb eng Nosaki, Kaname verfasserin aut Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Elsevier Saka, Hideo oth Hosomi, Yukio oth Baas, Paul oth de Castro, Gilberto oth Reck, Martin oth Wu, Yi-Long oth Brahmer, Julie R. oth Felip, Enriqueta oth Sawada, Takeshi oth Noguchi, Kazuo oth Han, Shi Rong oth Piperdi, Bilal oth Kush, Debra A. oth Lopes, Gilberto oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:135 year:2019 pages:188-195 extent:8 https://doi.org/10.1016/j.lungcan.2019.07.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 135 2019 188-195 8 |
| allfieldsGer |
10.1016/j.lungcan.2019.07.004 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica (DE-627)ELV047696990 (ELSEVIER)S0169-5002(19)30527-6 DE-627 ger DE-627 rakwb eng Nosaki, Kaname verfasserin aut Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Elsevier Saka, Hideo oth Hosomi, Yukio oth Baas, Paul oth de Castro, Gilberto oth Reck, Martin oth Wu, Yi-Long oth Brahmer, Julie R. oth Felip, Enriqueta oth Sawada, Takeshi oth Noguchi, Kazuo oth Han, Shi Rong oth Piperdi, Bilal oth Kush, Debra A. oth Lopes, Gilberto oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:135 year:2019 pages:188-195 extent:8 https://doi.org/10.1016/j.lungcan.2019.07.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 135 2019 188-195 8 |
| allfieldsSound |
10.1016/j.lungcan.2019.07.004 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica (DE-627)ELV047696990 (ELSEVIER)S0169-5002(19)30527-6 DE-627 ger DE-627 rakwb eng Nosaki, Kaname verfasserin aut Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies 2019 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Elsevier Saka, Hideo oth Hosomi, Yukio oth Baas, Paul oth de Castro, Gilberto oth Reck, Martin oth Wu, Yi-Long oth Brahmer, Julie R. oth Felip, Enriqueta oth Sawada, Takeshi oth Noguchi, Kazuo oth Han, Shi Rong oth Piperdi, Bilal oth Kush, Debra A. oth Lopes, Gilberto oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:135 year:2019 pages:188-195 extent:8 https://doi.org/10.1016/j.lungcan.2019.07.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 135 2019 188-195 8 |
| language |
English |
| source |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:135 year:2019 pages:188-195 extent:8 |
| sourceStr |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:135 year:2019 pages:188-195 extent:8 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
ESMO JLCS ECOG PS AE NSCLC OS Q3W TPS PD-L1 HR PD-1 |
| isfreeaccess_bool |
false |
| container_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| authorswithroles_txt_mv |
Nosaki, Kaname @@aut@@ Saka, Hideo @@oth@@ Hosomi, Yukio @@oth@@ Baas, Paul @@oth@@ de Castro, Gilberto @@oth@@ Reck, Martin @@oth@@ Wu, Yi-Long @@oth@@ Brahmer, Julie R. @@oth@@ Felip, Enriqueta @@oth@@ Sawada, Takeshi @@oth@@ Noguchi, Kazuo @@oth@@ Han, Shi Rong @@oth@@ Piperdi, Bilal @@oth@@ Kush, Debra A. @@oth@@ Lopes, Gilberto @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002331438 |
| id |
ELV047696990 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047696990</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624140810.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191022s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2019.07.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047696990</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(19)30527-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nosaki, Kaname</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ESMO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">JLCS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ECOG PS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NSCLC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Q3W</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TPS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-L1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saka, Hideo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hosomi, Yukio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baas, Paul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Castro, Gilberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reck, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Yi-Long</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brahmer, Julie R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Felip, Enriqueta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sawada, Takeshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Noguchi, Kazuo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Han, Shi Rong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Piperdi, Bilal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kush, Debra A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lopes, Gilberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:135</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:188-195</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2019.07.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">135</subfield><subfield code="j">2019</subfield><subfield code="h">188-195</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Nosaki, Kaname |
| spellingShingle |
Nosaki, Kaname Elsevier ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies |
| authorStr |
Nosaki, Kaname |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002331438 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 Elsevier |
| topic |
Elsevier ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 |
| topic_unstemmed |
Elsevier ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 |
| topic_browse |
Elsevier ESMO Elsevier JLCS Elsevier ECOG PS Elsevier AE Elsevier NSCLC Elsevier OS Elsevier Q3W Elsevier TPS Elsevier PD-L1 Elsevier HR Elsevier PD-1 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h s hs y h yh p b pb c g d cg cgd m r mr y l w ylw j r b jr jrb e f ef t s ts k n kn s r h sr srh b p bp d a k da dak g l gl |
| hierarchy_parent_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| hierarchy_parent_id |
ELV002331438 |
| hierarchy_top_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002331438 |
| title |
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies |
| ctrlnum |
(DE-627)ELV047696990 (ELSEVIER)S0169-5002(19)30527-6 |
| title_full |
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies |
| author_sort |
Nosaki, Kaname |
| journal |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| journalStr |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
188 |
| author_browse |
Nosaki, Kaname |
| container_volume |
135 |
| physical |
8 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Nosaki, Kaname |
| doi_str_mv |
10.1016/j.lungcan.2019.07.004 |
| title_sort |
safety and efficacy of pembrolizumab monotherapy in elderly patients with pd-l1–positive advanced non–small-cell lung cancer: pooled analysis from the keynote-010, keynote-024, and keynote-042 studies |
| title_auth |
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies |
| abstract |
• Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. |
| abstractGer |
• Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. |
| abstract_unstemmed |
• Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies |
| url |
https://doi.org/10.1016/j.lungcan.2019.07.004 |
| remote_bool |
true |
| author2 |
Saka, Hideo Hosomi, Yukio Baas, Paul de Castro, Gilberto Reck, Martin Wu, Yi-Long Brahmer, Julie R. Felip, Enriqueta Sawada, Takeshi Noguchi, Kazuo Han, Shi Rong Piperdi, Bilal Kush, Debra A. Lopes, Gilberto |
| author2Str |
Saka, Hideo Hosomi, Yukio Baas, Paul de Castro, Gilberto Reck, Martin Wu, Yi-Long Brahmer, Julie R. Felip, Enriqueta Sawada, Takeshi Noguchi, Kazuo Han, Shi Rong Piperdi, Bilal Kush, Debra A. Lopes, Gilberto |
| ppnlink |
ELV002331438 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.lungcan.2019.07.004 |
| up_date |
2024-07-06T16:51:30.867Z |
| _version_ |
1803849240012652544 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047696990</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624140810.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191022s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2019.07.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000938.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047696990</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(19)30527-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nosaki, Kaname</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Pooled analysis of elderly patients (≥75 y) from KEYNOTE-010, -024, and -042. • Pembrolizumab improved survival vs chemotherapy for PD-L1‒positive advanced NSCLC. • No unexpected toxicity with pembrolizumab was observed in elderly patients. • Pembrolizumab outcomes in the elderly were consistent with overall study population.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ESMO</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">JLCS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ECOG PS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NSCLC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Q3W</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TPS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-L1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saka, Hideo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hosomi, Yukio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baas, Paul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Castro, Gilberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reck, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Yi-Long</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brahmer, Julie R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Felip, Enriqueta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sawada, Takeshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Noguchi, Kazuo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Han, Shi Rong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Piperdi, Bilal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kush, Debra A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lopes, Gilberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:135</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:188-195</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2019.07.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">135</subfield><subfield code="j">2019</subfield><subfield code="h">188-195</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.39787 |